YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

Related Keywords

Lahore ,Punjab ,Pakistan ,United States ,Singapore ,Philippines ,China ,Zenaida Mojares ,Alyssa Li ,Robin Yang ,Source Ys Biopharma Co Ltd ,Ys Biopharma Co Ltd ,Nasdaq ,Securities Exchange ,Trial Of The Company ,Principal Investigator ,Central Park Teaching Hospital ,Chief Medical Officer ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Business Combination ,Ys Biopharma Co ,Td ,